[EN] HCK INHIBITORS FOR THE TREATMENT OF FIBROSIS AND CANCER<br/>[FR] INHIBITEURS DE HCK POUR LE TRAITEMENT DE LA FIBROSE ET DU CANCER
申请人:ICAHN SCHOOL MED MOUNT SINAI
公开号:WO2020205921A1
公开(公告)日:2020-10-08
Compounds which are thiazole and triazole derivatives are disclosed, including compounds of the following genus: Formula I. The compounds are inhibitors of hematopoietic cell kinase (HCK) and exhibit anti-fibrotic and anti-proliferative effects. They are useful in the treatment of a variety of disorders, including a fibrosis or a fibrotic disease, such as renal fibrosis.
本发明揭示了噻唑和三唑衍生物的化合物,包括以下属的化合物:化学式I。这些化合物是造血细胞激酶(HCK)的抑制剂,具有抗纤维化和抗增殖作用。它们在治疗各种疾病中很有用,包括纤维化或纤维化疾病,如肾脏纤维化。